Ameriprise Financial (AMP) Set to Announce Earnings on Wednesday

Ameriprise Financial (NYSE:AMP) will issue its quarterly earnings data after the market closes on Wednesday, July 24th. Analysts expect the company to announce earnings of $4.00 per share for the quarter.

Ameriprise Financial (NYSE:AMP) last issued its earnings results on Wednesday, April 24th. The financial services provider reported $3.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.61 by $0.14. The business had revenue of $3.12 billion during the quarter, compared to analysts’ expectations of $3.03 billion. Ameriprise Financial had a net margin of 14.85% and a return on equity of 37.97%. The company’s revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.70 EPS. On average, analysts expect Ameriprise Financial to post $16 EPS for the current fiscal year and $18 EPS for the next fiscal year.

Shares of NYSE:AMP opened at $150.89 on Wednesday. The firm has a market cap of $20.12 billion, a PE ratio of 10.10 and a beta of 1.80. The stock’s fifty day simple moving average is $147.83. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.81 and a current ratio of 0.81. Ameriprise Financial has a 1-year low of $95.69 and a 1-year high of $153.91.

Several research firms have recently commented on AMP. Argus began coverage on shares of Ameriprise Financial in a research note on Friday, July 5th. They issued a “buy” rating for the company. Zacks Investment Research cut shares of German American Bancorp. from a “buy” rating to a “hold” rating in a research note on Tuesday, April 30th. Barclays raised their target price on shares of T. Rowe Price Group from $90.00 to $95.00 and gave the stock an “underweight” rating in a research note on Thursday, April 25th. Morgan Stanley raised their target price on shares of Williams-Sonoma from $52.00 to $56.00 and gave the stock an “underweight” rating in a research note on Wednesday, July 10th. Finally, ValuEngine cut shares of Wave Life Sciences from a “buy” rating to a “hold” rating in a research note on Tuesday, April 16th. Two equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $173.56.

In other news, EVP Randy Kupper sold 5,160 shares of Ameriprise Financial stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $150.38, for a total transaction of $775,960.80. Following the sale, the executive vice president now owns 23,656 shares in the company, valued at $3,557,389.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.90% of the company’s stock.

Ameriprise Financial Company Profile

Ameriprise Financial, Inc, through its subsidiaries, provides various financial products and services to individual and institutional clients in the United States and internationally. It operates through five segments: Advice & Wealth Management, Asset Management, Annuities, Protection, and Corporate & Other.

Further Reading: What is a capital gains distribution?

Earnings History for Ameriprise Financial (NYSE:AMP)

Receive News & Ratings for Ameriprise Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ameriprise Financial and related companies with's FREE daily email newsletter.